Thymidine kinase-mediated killing of rat brain tumors

David BarbaDepartment of Surgery, Division of Neurosurgery, and Department of Neurosciences, School of Medicine, University of California, San Diego, California

Search for other papers by David Barba in
Current site
Google Scholar
PubMed
Close
 M.D.
,
Joseph HardinDepartment of Surgery, Division of Neurosurgery, and Department of Neurosciences, School of Medicine, University of California, San Diego, California

Search for other papers by Joseph Hardin in
Current site
Google Scholar
PubMed
Close
,
Jasodhara RayDepartment of Surgery, Division of Neurosurgery, and Department of Neurosciences, School of Medicine, University of California, San Diego, California

Search for other papers by Jasodhara Ray in
Current site
Google Scholar
PubMed
Close
 Ph.D.
, and
Fred H. GageDepartment of Surgery, Division of Neurosurgery, and Department of Neurosciences, School of Medicine, University of California, San Diego, California

Search for other papers by Fred H. Gage in
Current site
Google Scholar
PubMed
Close
 Ph.D.
View More View Less
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $525.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $624.00
USD  $45.00
USD  $525.00
USD  $624.00
Print or Print + Online Sign in

✓ Gene therapy has many potential applications in central nervous system (CNS) disorders, including the selective killing of tumor cells in the brain. A rat brain tumor model was used to test the herpes simplex virus (HSV)-thymidine kinase (TK) gene for its ability to selectively kill C6 and 9L tumor cells in the brain following systemic administration of the nucleoside analog ganciclovir. The HSV-TK gene was introduced in vitro into tumor cells (C6-TK and 9L-TK), then these modified tumor cells were evaluated for their sensitivity to cell killing by ganciclovir. In a dose-response assay, both C6-TK and 9L-TK cells were 100 times more sensitive to killing by ganciclovir (median lethal dose: C6-TK, 0.1 µg ganciclovir/ml; C6, 5.0 µg ganciclovir/ml) than unmodified wild-type tumor cells or cultured fibroblasts.

In vivo studies confirmed the ability of intraperitoneal ganciclovir administration to kill established brain tumors in rats as quantified by both stereological assessment of brain tumor volumes and studies of animal survival over 90 days. Rats with brain tumors established by intracerebral injection of wild-type or HSV-TK modified tumor cells or by a combination of wild-type and HSV-TK-modified cells were studied with and without ganciclovir treatments. Stereological methods determined that ganciclovir treatment eliminated tumors composed of HSV-TK-modified cells while control tumors grew as expected (p < 0.001). In survival studies, all 10 rats with 9L-TK tumors treated with ganciclovir survived 90 days while all untreated rats died within 25 days. Curiously, tumors composed of combinations of 9L and 9L-TK cells could be eliminated by ganciclovir treatments even when only one-half of the tumor cells carried the HSV-TK gene. While not completely understood, this additional tumor cell killing appears to be both tumor selective and local in nature. It is concluded that HSV-TK gene therapy with ganciclovir treatment does selectively kill tumor cells in the brain and has many potential applications in CNS disorders, including the treatment of cancer.

  • Collapse
  • Expand
  • 1.

    Bookstein R, , Shew JY, & Chen PL, et al: Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated Rβ gene. Science 247:712715, 1990 Bookstein R, Shew JY, Chen PL, et al: Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated Rβ gene. Science 247:712–715, 1990

    • Search Google Scholar
    • Export Citation
  • 2.

    Culver KW, , Ram Z, & Wallbridge S, et al: In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256:15501552, 1992 Culver KW, Ram Z, Wallbridge S, et al: In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256:1550–1552, 1992

    • Search Google Scholar
    • Export Citation
  • 3.

    Ezzeddine ZD, , Martuza RL, & Platika D, et al: Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. New Biol 3:608614, 1991 Ezzeddine ZD, Martuza RL, Platika D, et al: Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. New Biol 3:608–614, 1991

    • Search Google Scholar
    • Export Citation
  • 4.

    Gage FH, , Kawaja MD, & Fisher LJ: Genetically modified cells: applications for intracerebral grafting. Trends Neurosci 14:328333, 1991 Gage FH, Kawaja MD, Fisher LJ: Genetically modified cells: applications for intracerebral grafting. Trends Neurosci 14:328–333, 1991

    • Search Google Scholar
    • Export Citation
  • 5.

    Gage FH, , Wolff JA, & Rosenberg MB, et al: Grafting genetically modified cells to the brain: possibilities for the future. Neuroscience 23:795807, 1987 Gage FH, Wolff JA, Rosenberg MB, et al: Grafting genetically modified cells to the brain: possibilities for the future. Neuroscience 23:795–807, 1987

    • Search Google Scholar
    • Export Citation
  • 6.

    Gundersen HJG, , Bagger P, & Bendtsen TF, et al: The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96:857881, 1988 Gundersen HJG, Bagger P, Bendtsen TF, et al: The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96:857–881, 1988

    • Search Google Scholar
    • Export Citation
  • 7.

    Gundersen HJG, , Bendtsen TF, & Korbo L, et al: Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 96:379394, 1988 Gundersen HJG, Bendtsen TF, Korbo L, et al: Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 96:379–394, 1988

    • Search Google Scholar
    • Export Citation
  • 8.

    Horellou P, , Brundin P, & Kalén P, et al: In vivo release of DOPA and dopamine from genetically engineered cells grafted to the denervated rat striatum. Neuron 5:393402, 1990 Horellou P, Brundin P, Kalén P, et al: In vivo release of DOPA and dopamine from genetically engineered cells grafted to the denervated rat striatum. Neuron 5:393–402, 1990

    • Search Google Scholar
    • Export Citation
  • 9.

    Martuza RL, , Malick A, & Markert JM, et al: Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 252:854856, 1991 Martuza RL, Malick A, Markert JM, et al: Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 252:854–856, 1991

    • Search Google Scholar
    • Export Citation
  • 10.

    Moolten FL: Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 46:52765281, 1986 Moolten FL: Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 46:5276–5281, 1986

    • Search Google Scholar
    • Export Citation
  • 11.

    Moolten FL, & Wells JM: Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst 82:297300, 1990 Moolten FL, Wells JM: Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst 82:297–300, 1990

    • Search Google Scholar
    • Export Citation
  • 12.

    Plautz G, , Nabel EG, & Nabel GJ: Selective elimination of recombinant genes in vivo with a suicide retroviral vector. New Biol 3:709715, 1991 Plautz G, Nabel EG, Nabel GJ: Selective elimination of recombinant genes in vivo with a suicide retroviral vector. New Biol 3:709–715, 1991

    • Search Google Scholar
    • Export Citation
  • 13.

    Short MP, , Choi BC, & Lee JK, et al: Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line. J Neurosci Res 27:427433, 1990 Short MP, Choi BC, Lee JK, et al: Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line. J Neurosci Res 27:427–433, 1990

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 750 354 3
Full Text Views 185 5 0
PDF Downloads 127 13 0
EPUB Downloads 0 0 0